Structure of SARS-CoV-2 Main Protease as a Basis for Drug Design

  • Author: ChemistryViews.org
  • Published: 21 March 2020
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
  • Source / Publisher: Science/American Association for the Advancement of Science
thumbnail image: Structure of SARS-CoV-2 Main Protease as a Basis for Drug Design

The coronavirus SARS-CoV-2 causes the current outbreak of the respiratory disease COVID-19. Antiviral medication to treat COVID-19 is urgently needed. A possible drug target in coronaviruses is the main protease (Mpro also called 3CLpro), an enzyme that is essential for replication of the virus.


Rolf Hilgenfeld, University of Lübeck, Germany, and colleagues have recently designed and synthesized peptidomimetic α-ketoamides to be used as inhibitors of the main proteases of coronaviruses. To allow the design of improved α-ketoamide inhibitors, the researchers have determined the crystal structure of the Mpro of SARS-CoV-2 at a resolution of 1.75 Å using X-ray crystallography.


The structure is very similar to the Mpro of the related SARS virus. It is a dimer that features six-stranded antiparallel β-barrels, with the substrate-binding site between them, and a cluster of five helices involved in dimerization of the enzyme. The team used the crystal structure to investigate the interactions of Mpro with α-ketoamides and optimize the substituents of the drug candidates. They obtained a potent inhibitor of the SARS-CoV-2 Mpro. The optimized drug candidate showed promising properties in a mouse study: It remains in the lung tissue for some time and could potentially be administered directly by inhalation.



Also of Interest

 

 

 

 

 

Article Views: 1326

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)published by Wiley-VCH